Organovo Partners with new Manufacturing USA Institute to Advance development of NexGen technologies for Cells, Tissues and Organs

1 Mins read
Leading 3D printing companies

Image Credit: Organovo

Organovo Holdings, Inc. one of the largest 3D printing companies in the world announced that it has joined a new public-private manufacturing USA initiative – the Advanced Regenerative Manufacturing  Institute (ARMI) – a consortium of nearly 100 industry, government and academia that works towards advancing the development of next-generation manufacturing processes and technologies for cells, tissues and organs.

The ARMI is a public-private network that invests in the development of world-class manufacturing technologies where ARMI integrates and organises the fragmented collection of industry practices and domestic capabilities in tissue Biofabrication technology.

Also Read: Organovo Achieves Key Development Milestones for its 3D Bioprinted Liver and Intestinal Tissue Models

In addition to biofabrication technology, the ARMI will also advance regenerative tissue research and will focus on creating advanced manufacturing innovations in biomaterial and cell processing for critical Department of Defense and civilian needs.

Speaking about the need to develop new technologies for engineered tissue manufacturing, Dean Kamen, ARMI’s Chairman, said, “We need to develop 21st century tools for engineered tissue manufacturing that will allow these innovations to be widely available.”

Don’t Miss: EasyRx and 3D Systems to Offer Integrated Orthodontic Software Solution

Explaining the benefits of joining the initiative, Dr. Sharon Presnell, Chief Scientific Officer at Organovo said, “By joining ARMI, we connect with a valuable network of resources focused on the development of standards and robust production methods that are critical to the long-term success of creating cell-based products,”

“Organovo’s mission to deliver game-changing regenerative medicine products and in vitro liver models depends not only on a supply of well-qualified cellular raw materials, but also on our ability to further streamline and automate tissue production processes such as bioprinting and post-fabrication conditioning.  By joining the ARMI group, we have the opportunity to learn from other innovators, to share what we have learned, and develop partnerships that bring ground-breaking products to the market,” Presnell concluded.

About Manufactur3D Magazine: Manufactur3D is an online magazine on 3D Printing. We offer 3D printing news, insights and analysis from all around the world. To stay up-to-date about the latest happenings in the 3D printing world, like us on Facebook or follow us on Google+

2016 posts

About author
Manufactur3D is an Indian Online 3D Printing Media Platform that reports on the latest news, insights and analysis from the Indian and the Global 3D Printing Industry.
Related posts

Stratasys updates Industrial and Healthcare Business Unit products and Stratasys Direct

2 Mins read
Stratasys announced improvements to many Industrial and Healthcare Business Unit products, as well as Stratasys Direct. The company has

India’s Incredible 3D achieves a milestone of 3000 Patient Specific Implants

1 Mins read
Incredible 3D recently celebrated a milestone of successfully achieving over 3,000 patient specific implants in April 2024.

New 3D Printed Films to localise chemotherapy

2 Mins read
University of South Australia research team is revolutionising liver cancer treatment by using 3D printed films to localise chemotherapy at surgical

Leave a Reply